Maximus vs Brello: Telemedicine semaglutide cost and access
Quick verdict: Maximus provides a clearly documented, low flat rate compounded semaglutide program with telemedicine access and US pharmacy fulfillment; Brello’s public details could not be verified and requires clinician review before treatment.
The comparison Maximus vs Brello centers on three core differences supported by the sources: price and transparency, verification and program detail, and regulatory and availability notes. Below I compare these points directly to help decide which fits your needs.
Price and program transparency
Maximus lists a clear starting price and multiple pricing notes. Maximus advertises a starting price of $132.99 per month for compounded semaglutide and references mid-range values such as $79.99/month and starting-at figures. Maximus describes no membership fees, transparent pricing, free expedited shipping, and a direct-pay model. Brello’s pricing and terms were not verified on the captured landing page, so public cost details are not supplied.
Verification, clinician review, and how treatment is approved
Both sources emphasize clinician involvement. Maximus states prescriptions are approved by licensed doctors through telemedicine and that if you are not approved for treatment, medication costs will be fully refunded. Brello’s captured evidence is limited, but explicitly states treatment is available only when a licensed clinician determines it is medically appropriate. Unlike Maximus, Brello’s captured landing page did not publish detailed enrollment, pricing, or availability steps.
Regulatory notes and medication sourcing
Maximus fills prescriptions through trusted U.S. pharmacies and notes its medication is compounded. The regulatory note supplied with Maximus and Brello is consistent: compounded medications are not FDA approved and are not reviewed by FDA for safety, effectiveness or quality. Maximus also highlights compounded-in-US pharmacies and domestic sourcing as reassurance. For Brello, medication-specific approval status must be confirmed and the captured evidence warns that branded and compounded products are not interchangeable.
Availability and state coverage
Maximus states its Weight Loss Protocol is currently available in all 50 states except Mississippi. Brello’s state coverage was not published or could not be verified on the captured landing page, so state availability is not supplied for Brello.
Direct differences at a glance
| Criteria | Maximus | Brello |
|---|---|---|
| Starting price | $132.99 per month; multiple starting references including $79.99/month | Not verified on captured landing page |
| Prescription approval | Prescriptions approved by licensed doctors via telemedicine | Treatment only when a licensed clinician determines it is medically appropriate |
| Medication sourcing | Compounded in U.S. pharmacies | Not verified; medication-specific approval must be confirmed |
| Regulatory note | Compounded medications are not FDA approved | Compounded medications are not FDA reviewed for safety, effectiveness or quality |
| State availability | Available in all 50 states except Mississippi | Not verified |
| Refund if not approved | Medication costs fully refunded if not approved for treatment | Not supplied |
Practical implications for patients
Choosing between Maximus vs Brello depends on whether transparent pricing and documented availability matter more to you than confirming eligibility through clinician review first. Maximus supplies concrete price points, telemedicine access, US pharmacy fulfillment, and a refund policy if not approved. Brello’s captured evidence stresses clinician review but lacks publicly captured pricing, pharmacy, and state coverage details, so prospective patients should verify those elements directly with Brello before enrolling.
What is not supplied
The captured Brello landing page did not publish readable pricing, shipping, membership, or renewal terms. Details on branded product availability, tirzepatide offerings, or broader outcome guarantees were not supplied for Brello. Maximus does not publish a weight loss guarantee or branded product availability beyond compounded semaglutide in the captured evidence.
Conclusion and final recommendation
In a direct comparison of Maximus vs Brello based only on the supplied evidence, Maximus is the clearer option if you prioritize transparent starting pricing, telemedicine prescriptions approved by licensed doctors, US pharmacy compounding, and stated state availability. Brello requires contacting the provider or clinician because pricing, pharmacy sourcing, state coverage, and renewal terms were not verified on the captured page.
Choose Maximus if you want a low flat-rate, direct-pay semaglutide program with documented telemedicine approval and US pharmacy fulfillment. Choose Brello if you prefer to confirm eligibility, medication options, total cost, renewal terms and state availability with a clinician before enrolling.